EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color ( PSPC ) and Myo‐ Inositol ( MI ) Treatment for Motor Related and Behavioral Phenotypes in a Mouse Model of Classic Galactosemia

Olivia Bellagamba, Aaron J Guo, Sandhya Senthilkumar, Synneva Hagen Lillevik, Davide De Biase, Kent Lai, Bijina Balakrishnan

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Olivia Bellagamba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Galactosemias, Inositol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development, Galactosemia Foundation, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Classic galactosemia (CG) is a rare inherited metabolic disease caused by mutations in the GALT gene encoding the enzyme galactose‐1 phosphate uridylyltransferase in galactose metabolism. The condition develops as a potentially fatal illness during the newborn period, but its acute clinical manifestations can be alleviated through a galactose restricted diet. Nonetheless, such dietary intervention is inadequate in preventing significant long‐term consequences, including neurological impairments, growth restriction, cognitive delays, and, for most females, primary ovarian insufficiency. At present, no effective therapy exists to stop the progression of these complications, highlighting the urgent need for new treatment approaches to be developed. Supplements have been used in the treatment of other inborn errors of metabolism; however, they are not typically included in the clinical therapeutic regimen for CG. Recently, our research team has demonstrated that two generally recognized as safe supplements (purple weet potato color, PSPC and myo ‐inositol, MI) have been effective in partially restoring functions in the ovaries of our GalT ‐KO mouse model. However, the toxicological profile of both PSPC and MI has not been determined. In this study, we investigated the acute (30 days) and chronic (180 days) oral toxicities of PSPC and MI both in WT control and GalT ‐KO mice. Furthermore, our study aims to evaluate the effectiveness of oral feeding of PSPC and MI in correcting motor‐related and behavioral phenotypes in GalT ‐KO mice. The long‐term treatment of MI at a lower dose demonstrated promising improvements in motor deficit and anxiety driven hyperactivity in the mutant mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalactosemiasInositolAnimalsDisease Models, AnimalFemaleMicePhenotypeMice, KnockoutUTP-Hexose-1-Phosphate UridylyltransferaseBehavior, AnimalDietary SupplementsMotor Activity

Stichwörter der Autor:innen

antioxidantclassic galactosemiacomposite phenotype scoringmotor impairmentmyo‐inositolopen field testpurple sweet potato colorsupplements

Substanzen

InositolUTP-Hexose-1-Phosphate Uridylyltransferase

Autor:innen und Institutionen

  • Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Department of Pediatrics, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.
  • Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.
  • Department of Nutrition and Integrative Physiology, College of Health, University of Utah, Salt Lake City, Utah, USA.

Förderung

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Galactosemia Foundation
  • NICHD NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Bellagamba, O., Guo, A. J., Senthilkumar, S., Lillevik, S. H., De Biase, D., Lai, K., & Balakrishnan, B. (2025). Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color ( PSPC ) and Myo‐ Inositol ( MI ) Treatment for Motor Related and Behavioral Phenotypes in a Mouse Model of Classic Galactosemia. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70002

Vancouver

Bellagamba O, Guo AJ, Senthilkumar S, Lillevik SH, De Biase D, Lai K, et al. Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color ( PSPC ) and Myo‐ Inositol ( MI ) Treatment for Motor Related and Behavioral Phenotypes in a Mouse Model of Classic Galactosemia. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70002

BibTeX
@article{Bellagamba2025,
  author = {Bellagamba, Olivia and Guo, Aaron J and Senthilkumar, Sandhya and Lillevik, Synneva Hagen and De Biase, Davide and Lai, Kent and Balakrishnan, Bijina},
  title = {Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color ( PSPC ) and Myo‐ Inositol ( MI ) Treatment for Motor Related and Behavioral Phenotypes in a Mouse Model of Classic Galactosemia},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70002}
}
Kostenlos starten →